Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ALKERMES reported $58.18M in Cost of Sales for its fiscal quarter ending in March of 2023.

Cost Of Sales Change
AbbVie ABBV:US USD 3.97B 200M
Acadia Pharmaceuticals ACAD:US USD 1.67M 746K
Acorda Therapeutics ACOR:US USD 3.23M 1.33M
Amgen AMGN:US USD 1.68B 65M
Biogen BIIB:US USD 662.8M 91.9M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
Bluebird Bio BLUE:US USD 3.38M 3.36M
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Coherus Biosciences CHRS:US USD 16.87M 2.67M
Eli Lilly LLY:US USD 1.63B 78.6M
Gilead Sciences GILD:US USD 1.4B 5M
Heron Therapeutics HRTX:US USD 16.85M 4.23M
Horizon Pharma HZNP:US USD 208.56M 32.22M
Intra Cellular Therapies ITCI:US USD 6.75M 37K
Ionis Pharmaceuticals IONS:US USD 1.34M 2.34M
J&J JNJ:US USD 8.4B 684M
Marinus Pharmaceuticals MRNS:US USD 206K 86K
Merck & Co MRK:US USD 3.35B 491M
Nektar Therapeutics NKTR:US USD 7.06M 827K
Neurocrine Biosciences NBIX:US USD 8.5M 800K
Otsuka Holdings 4578:JP JPY 136.78B 5.71B
Pfizer PFE:US USD 5.03B 4.8B
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Revance Therapeutics RVNC:US USD 16.17M 7.34M
Vertex Pharmaceuticals VRTX:US USD 266.9M 16.4M